Both in Pharmaceuticals
LB Pharmaceuticals vs UroGen Pharma
Over the past year LBRX returned +135.1% and URGN returned +33.2%; their daily moves had a correlation of 0.11.
LBRX +135.1% URGN +33.2%Growth of $1, one year, split-adjusted
| Metric | LBRX | URGN |
|---|---|---|
| Price | $38.09 | $25.73 |
| Market cap | $1.23B | $1.26B |
| Today | −6.76% | −10.47% |
| 1 month | +11.5% | −36.8% |
| 6 months | +19.1% | −3.2% |
| Year to date | +71.1% | +9.9% |
| 1 year | +130.8% | +29.9% |
| Revenue growth (YoY) | — | +199.2% |
| Gross margin | — | 90.9% |
| Net margin | — | −19.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 6.7× |
| Net cash | $327.8M | -$85.1M |
| Dividend yield | — | — |
| Volatility (60d) | 53.3% | 57.8% |
| Short % of float | 23.0% | 12.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).